{
  "url": "https://struct.news/briefs/elanco-grew-sales-by-21-but-receivables-grew-faster",
  "title": "Elanco grew sales by 21%, but receivables grew faster",
  "summary": "Cash fell from $505 million to $428 million during a three-month period that produced $57 million of net income.",
  "published_at": "2026-08-05T13:08:16.296200+00:00",
  "publisher": "Struct",
  "usage": "Figures are as reported by the company. Quote with attribution to the source filing.",
  "company": {
    "name": "Elanco Animal Health Incorporat",
    "ticker": "ELAN",
    "cik": "1739104",
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - Specialty & Generic"
  },
  "source_filing": {
    "form": "10-Q",
    "filed": "2026-05-06",
    "accession": "0001739104-26-000030",
    "url": "https://www.sec.gov/Archives/edgar/data/1739104/000173910426000030/elan-20260331.htm"
  },
  "comparison_filing": {
    "form": "10-Q",
    "filed": "2025-11-05",
    "url": "https://www.sec.gov/Archives/edgar/data/1739104/000173910425000071/elan-20250930.htm"
  },
  "reported_figures": [
    {
      "group": "The filing in three numbers",
      "label": "Revenue",
      "value": 4715000000,
      "display": "$4.7B",
      "unit": "usd",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "sec_filing",
        "label": "Filed company results",
        "form": "10-Q",
        "accession": "0001739104-26-000030",
        "filing_date": "2026-05-06"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Revenue YoY",
      "value": 6.217616580310881,
      "display": "+6.2%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001739104-26-000030",
        "filing_date": "2026-05-06"
      }
    },
    {
      "group": "The filing in three numbers",
      "label": "Net margin",
      "value": -4.920466595970307,
      "display": "-4.9%",
      "unit": "percent",
      "period": "2025-12-31",
      "detail": null,
      "source": {
        "kind": "jodie_calculation",
        "label": "Calculated from filed company results",
        "form": "10-Q",
        "accession": "0001739104-26-000030",
        "filing_date": "2026-05-06"
      }
    }
  ],
  "watch_next": [
    {
      "type": "demand",
      "statement": "Zenrelia, AdTab, parasiticide sales, and purchases by new corporate retail customers were the disclosed volume drivers for the latest three-month period.",
      "importance": "medium",
      "evidence": "Higher volumes were primarily driven by new products, led by Zenrelia and AdTab, and higher parasiticide sales, including increased purchases by a couple new corporate retail customers.",
      "source_date": "2026-05-06"
    }
  ],
  "related_tickers": [
    "ELAN"
  ],
  "disclaimer": "Descriptive reporting of filed results. Not investment advice, and contains no forecast or recommendation."
}